JudithWhiteMD

Internal Medicine • Orlando, FL

Holston Medical Group

Join to view full profile

Dr. White is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. White's full profile

Already have an account?

Office
100 W Gore St
Ste 202
Orlando, FL 32806
Phone+1 423-292-9352

Education & Training

University of Tennessee College of Medicine at ChattanoogaResidency, Internal Medicine, 1984 - 1987
Louisiana State University School of Medicine in New OrleansClass of 1984

Certifications & Licensure

FL State Medical License 2015 - 2026
TN State Medical License 1985 - 2016
VA State Medical License 2001 - 2016
LA State Medical License 1984 - 1986
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2013
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2013

Clinical Trials

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
Completed
Phase 2
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Terminated
Phase 3

Publications & Presentations

PubMed

20 citations
A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate ...
Judith L White, Patricia Buchanan, Jia Li, Robert Frederich
BMC Endocrine Disorders. 2014-02-24

Press Mentions

Mriglobal Chief Science Advisor Part of Ambitious Pandemic Response Team to Speed Drug Cocktails for Covid-19 and Future Deadly Virus Waiting in the WingsJanuary 5th, 2022
‘Weeks, Not Months’: Scientists Develop Ambitious Pandemic Response PlanDecember 22nd, 2021
Treatments in Weeks, Not Months: Scientists Develop Ambitious Pandemic Response PlanDecember 21st, 2021